Gary Hoel, RPh, PhD
Watson Laboratories, Inc. · Watson Pharmaceuticals · WATSON LPHARMACEUTICAL
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gary Hoel, RPh, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:51 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT00224003 · Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis PatientsWatson Pharmaceuticals · completed · Anemia · study director
- Ph4NCT00224016 · Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological ConditionWatson Pharmaceuticals · completed · Detrusor Hyperreflexia · study chair
- Ph2/Ph3NCT00223977 · 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.Watson Pharmaceuticals · completed · Iron Deficiency Anemia · study chair
- Ph4NCT00223964 · Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis PatientsWatson Pharmaceuticals · completed · Anemia · study director
- Ph4NCT00224029 · A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological ConditionWatson Pharmaceuticals · completed · Detrusor Hyperreflexia · study director
- Ph4NCT00223938 · Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.Sanofi · terminated · Anemia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.